An intracellular iron storage protein complex consisting of 24 subunits (heavy H-chain and light L-chain) that can sequester up to 4,500 iron atoms in a mineralized ferric core, serving as the body's primary iron reserve in liver, spleen, bone marrow, and macrophages. Small amounts appear in serum (0.5-1% of total body ferritin) where serum ferritin functions as both an acute phase reactant during inflammation and a clinical biomarker of total body iron stores—though inflammation confounds this relationship.
Ferritin is like a high-security vault inside every cell's warehouse. Each vault (ferritin protein shell) can hold up to 4,500 iron coins, keeping them locked away where they can't rust (oxidize) the warehouse machinery. The liver, spleen, and bone marrow are the main distribution centers with the biggest vault collections. When everything's running smoothly, the warehouse manager (ferroportin) can open vaults and export iron to where it's needed—like the bone marrow mint that makes red blood cell currency (hemoglobin).
But when infection or inflammation hits, it's like a security lockdown: the police (IL-6) radio headquarters (liver) to release hepcidin, which handcuffs all the warehouse managers (blocks ferroportin). Now iron can't leave—it just piles up in more and more vaults. This nutritional immunity strategy starves invading bacteria of iron they desperately need. Meanwhile, a few vaults leak into the bloodstream (serum ferritin), and security uses this as a burglar alarm—high serum ferritin screams "lockdown in progress!" even when the vaults might not be full. A doctor measuring serum ferritin during a lockdown can't tell if the warehouse is genuinely overflowing with iron or just on high alert.
graph TD
A[Iron enters cell via DMT1/Transferrin receptor] --> B[Cytoplasmic iron pool]
B --> C{Iron Regulatory Proteins IRPs}
C -->|High iron| D[IRPs release from ferritin mRNA]
D --> E[Ferritin translation increases]
E --> F[24 subunits self-assemble into apoferritin shell]
F --> G["Ferroxidase activity of H-chain oxidizes Fe2+ → Fe3+"]
G --> H["Up to 4500 Fe3+ atoms stored in mineralized core"]
I["Inflammation: pathogens/DAMPs"] --> J[Macrophages release IL-6]
J --> K["Liver hepatocytes: IL-6 binds IL-6R"]
K --> L[JAK-STAT3 pathway activation]
L --> M["STAT3 → nucleus → Hepcidin gene transcription"]
M --> N[Hepcidin secreted into blood]
N --> O[Hepcidin binds Ferroportin on macrophages/enterocytes]
O --> P[Ferroportin internalized & degraded]
P --> Q[Iron export blocked]
Q --> R["Intracellular iron accumulates → more ferritin synthesis"]
R --> S[Serum ferritin rises as acute phase protein]
H --> T["Ferritin prevents Fenton reaction: Fe2+ + H2O2 → OH• radicals"]
S --> U{Clinical interpretation}
U -->|"Ferritin <30 μg/L + low CRP"| V[True iron deficiency]
U -->|"Ferritin >200 μg/L + high CRP"| W[Inflammation masking true iron status]
U -->|"Ferritin >1000 μg/L"| X[Iron overload OR severe inflammation]
Detailed molecular cascade:
-
Normal iron homeostasis: Dietary iron (Fe2+) absorbed via DMT1 in duodenal enterocytes → enters bloodstream via ferroportin → oxidized to Fe3+ by ceruloplasmin → binds transferrin → delivered to cells via transferrin receptor endocytosis → enters cytoplasmic labile iron pool.
-
Ferritin synthesis regulation: Iron Regulatory Proteins (IRP1 and IRP2) bind to Iron Responsive Elements (IREs) on ferritin mRNA 5' UTR when iron is low, blocking translation. When cellular iron rises, IRP1 binds an iron-sulfur cluster and releases from mRNA; IRP2 is degraded. Ferritin mRNA is now translated → 24 subunits (mix of H-chain with ferroxidase activity and L-chain for nucleation) self-assemble into hollow apoferritin sphere.
-
Iron sequestration: H-chain ferroxidase converts Fe2+ to Fe3+ at entry channels → Fe3+ migrates to core → nucleates as ferrihydrite mineral (5Fe2O3·9H2O) → prevents iron-catalyzed Fenton reaction (Fe2+ + H2O2 → Fe3+ + OH• + OH⁻) and Haber-Weiss cycle that generate destructive hydroxyl radicals.
-
Hepcidin-ferroportin axis during inflammation:
- PAMPs or DAMPs activate macrophages → IL-6 secretion
- IL-6 binds IL-6R on hepatocytes → gp130 dimerization → JAK1/JAK2 activation → STAT3 phosphorylation
- pSTAT3 translocates to nucleus → binds hepcidin (HAMP gene) promoter → hepcidin transcription
- Hepcidin secreted into circulation → binds ferroportin on enterocytes, macrophages, hepatocytes
- Ferroportin phosphorylated by JAK2 → ubiquitinated → internalized → lysosomal degradation
- Iron export blocked → intracellular iron accumulates → further ferritin synthesis via IRE/IRP system
-
Serum ferritin elevation mechanisms:
- Minor baseline release: small percentage of cellular ferritin continuously secreted via non-classical pathway (lysosomal exocytosis)
- Acute phase response: IL-1β and IL-6 directly increase ferritin gene transcription (independent of cellular iron)
- Cell damage/necrosis: damaged hepatocytes or macrophages release ferritin
- Result: serum ferritin rises disproportionately to total body iron during inflammation
-
Iron mobilization when needed: When iron demand increases (erythropoiesis), ferritin core is reduced back to Fe2+ via NADH-dependent ferritin reductase → Fe2+ exits through channels → exported via ferroportin (if hepcidin low).
Ferritin assessment is central to cPNI diagnostics but requires context-dependent interpretation that integrates inflammatory status—exemplifying the cPNI principle that single biomarkers are meaningless without system-level analysis.
Diagnostic interpretation framework:
- <30 μg/L + normal CRP (
mg/L): True iron deficiency → assess for blood loss, malabsorption (coeliac disease, H. pylori gastritis), inadequate intake (vegan diet without supplementation)
- <30 μg/L + elevated CRP: May still represent iron deficiency despite inflammation partially raising ferritin—use transferrin saturation (<20%) and soluble transferrin receptor (elevated) to confirm
- 30-200 μg/L + elevated CRP: Ambiguous—could be adequate iron with inflammation, or iron deficiency masked by acute phase response
- >200 μg/L + elevated CRP >10 mg/L: Chronic inflammation driving ferritin elevation via hepcidin-ferroportin axis—seen in chronic infections, autoimmune disease, chronic low-grade inflammation
- >300 μg/L + transferrin saturation >45%: Suspect iron overload (hemochromatosis, repeated transfusions)
- >1000 μg/L: Severe inflammation (sepsis, macrophage activation syndrome) OR iron overload—requires immediate differentiation
cPNI Metamodel connections:
Metamodel 0 (Evolutionary mismatch): Nutritional immunity evolved when iron was scarce and infections frequent—modern processed food provides iron supplementation while chronic low-grade inflammation chronically activates hepcidin, creating functional iron deficiency despite adequate stores. This mismatch underlies anemia of chronic disease.
Selfish Immune System: During chronic inflammation, the immune system "selfishly" sequesters iron from erythropoiesis and mitochondrial enzymes to withhold it from pathogens, causing fatigue and anemia even when total body iron is normal—the selfish immune system prioritizes pathogen defense over host energy metabolism.
Module 4 connection (Selfish Systems): Elevated ferritin without true iron overload signals that the selfish immune system has hijacked iron metabolism. The brain experiences energy deficit (iron needed for cytochrome c oxidase in mitochondria), but the immune system maintains lockdown. This contributes to the HPA axis hyperactivation seen when selfish systems compete.
Clinical intervention implications:
-
Iron supplementation paradox: Giving oral iron when ferritin is elevated due to inflammation can worsen oxidative stress and feed siderophore-producing pathogens. First resolve inflammation, then reassess.
-
Lactoferrin production capacity (Module 7): Adequate iron stores (ferritin 50-100 μg/L without inflammation) necessary for neutrophils and mucosal cells to synthesize lactoferrin—an iron-binding antimicrobial protein. Chronic inflammation depletes functional iron availability, impairing lactoferrin-mediated first-line defense.
-
Anemia of chronic disease phenotype: High ferritin + low serum iron + low transferrin saturation + elevated CRP = functional iron deficiency from hepcidin overproduction. Intervention targets inflammation (omega-3 SPMs, curcumin, lifestyle), NOT iron supplementation.
-
Chronic infections maintaining high ferritin: Persistent viral infections (EBV, CMV), chronic bacterial infections (periodontal disease, SIBO), or parasites sustain IL-6 secretion → chronic hepcidin elevation → perpetually elevated ferritin. Treat the infection, not the ferritin.
-
Mitochondrial function assessment: Low-normal ferritin (<50 μg/L) in context of fatigue suggests iron-limited oxidative phosphorylation—iron is required for Complex I, II, III, IV assembly and iron-sulfur cluster enzymes in TCA cycle.
- Apoferritin shell is 12 nm diameter hollow sphere; fully loaded ferritin stores 4,500 Fe3+ atoms as 8 nm ferrihydrite core
- Serum ferritin <15 μg/L is 99% specific for iron deficiency; <30 μg/L recommended threshold in cPNI practice
- Ferritin H-chain gene located on chromosome 11; L-chain on chromosome 19—different tissue expression patterns
- Half-life of serum ferritin: 24-30 hours, allowing rapid changes with acute inflammation or cell damage
- 1 μg/L serum ferritin approximately equals 8-10 mg stored iron in iron-replete state (but not during inflammation)
- Hepcidin (25 amino acid peptide) half-life is only 3-5 minutes; must be continuously secreted to maintain ferroportin blockade
- Ferritin L-chain dominant in liver and spleen (long-term storage); H-chain dominant in heart and brain (quick iron turnover, antioxidant protection)
- CRP >10 mg/L can elevate ferritin by 30-50% independent of iron stores
- Glycosylated ferritin (in liver disease, cancer) has different properties than normal ferritin—less iron per molecule
- Extreme hyperferritinemia (>10,000 μg/L) seen in hemophagocytic lymphohistiocytosis, adult-onset Still's disease, catastrophic inflammation
- Iron — ferritin is the primary intracellular storage form preventing free iron toxicity while maintaining bioavailable reserve
- Hepcidin — master regulator that increases ferritin by blocking ferroportin-mediated iron export during inflammation and iron overload
- Ferroportin — sole iron exporter; hepcidin binding causes ferroportin degradation, trapping iron and forcing ferritin synthesis
- Interleukin-6 — inflammatory cytokine that stimulates hepatic hepcidin transcription via JAK-STAT3, driving ferritin elevation independent of iron stores
- Acute phase response — ferritin is a positive acute phase protein; synthesis increases during APR as part of nutritional immunity strategy
- Nutritional immunity — ferritin sequesters iron to withhold it from siderophore-dependent pathogens like E. coli, Salmonella, Mycobacterium
- Inflammation — chronic inflammation sustains hepcidin elevation causing functional iron deficiency despite normal/high ferritin
- Lactoferrin — neutrophils require adequate iron stores (ferritin-bound) to synthesize this iron-binding antimicrobial glycoprotein for pathogen sequestration
- Macrophages — major ferritin storage site; M1 macrophages retain iron via hepcidin-ferroportin axis during infection
- C-reactive protein — must be measured alongside ferritin to distinguish true iron status from inflammatory confounding; CRP >5 mg/L invalidates ferritin as pure iron marker
- Transferrin — plasma iron transport protein; transferrin saturation <20% with high ferritin indicates anemia of chronic disease
- Oxidative stress — ferritin prevents iron-catalyzed Fenton reaction (Fe2+ + H2O2 → OH• radicals) that damages lipids, proteins, DNA
- Anemia of chronic disease — characterized by elevated/normal ferritin, low serum iron, low transferrin saturation due to hepcidin-mediated iron sequestration
- Hemoglobin — iron from ferritin mobilized via ferroportin (when hepcidin low) is incorporated into heme for hemoglobin synthesis in developing erythrocytes
- Chronic low-grade inflammation — CLGi sustains low-level IL-6/hepcidin production, chronically elevating ferritin and impairing iron recycling
- Liver — hepatocytes are major ferritin storage depot and sole source of hepcidin production in response to IL-6, IL-1β, BMP6 signaling
- IL-1β — along with IL-6, directly stimulates ferritin gene transcription independent of cellular iron via NF-κB pathway
- DMT1 — divalent metal transporter 1 in duodenal enterocytes imports dietary Fe2+; hepcidin blocks basolateral ferroportin preventing absorbed iron from entering circulation
- Enterocytes — duodenal absorptive cells express ferroportin; hepcidin-induced ferroportin degradation traps absorbed iron in enterocytes as ferritin, which is lost when cells slough
- ATP production — iron-sulfur clusters in mitochondrial Complexes I-III and cytochrome c oxidase (Complex IV) require iron from ferritin stores; low functional iron impairs oxidative phosphorylation
- Mitochondrial dysfunction — inadequate iron availability (from inflammation-driven sequestration despite high ferritin) impairs electron transport chain assembly
- HIF — hypoxia-inducible factor regulation involves iron-dependent prolyl hydroxylases; ferritin status affects cellular oxygen sensing
- NLRP3 inflammasome — free iron activates NLRP3 via ROS generation; ferritin sequestration prevents this inflammasome trigger
- Coeliac disease — common cause of low ferritin via malabsorption; duodenal damage reduces iron uptake despite adequate dietary intake
- H. pylori — chronic gastric infection causes iron deficiency via occult bleeding and hypochlorhydria reducing Fe2+ solubility; also drives inflammation raising ferritin confusingly
- Sepsis — extreme ferritin elevation (>1000 μg/L) from massive IL-6/IL-1β surge plus hepatocyte damage releasing ferritin; correlates with mortality
- Rheumatoid arthritis — autoimmune condition with chronic IL-6 elevation causing persistently high ferritin (200-600 μg/L) and functional iron deficiency despite adequate stores
- Module 2: Iron storage and transport; ferritin as metabolic reserve; relationship to energy metabolism
- Module 4: Selfish immune system sequestering iron during inflammation; ferritin elevation as immune dominance marker
- Module 7: Diagnostic interpretation of ferritin in context of lactoferrin production capacity; iron panel analysis including ferritin, transferrin saturation, CRP